atazanavir sulfate has been researched along with cgp-56697 in 1 studies
| Studies (atazanavir sulfate) | Trials (atazanavir sulfate) | Recent Studies (post-2010) (atazanavir sulfate) | Studies (cgp-56697) | Trials (cgp-56697) | Recent Studies (post-2010) (cgp-56697) |
|---|---|---|---|---|---|
| 1,102 | 246 | 590 | 751 | 251 | 589 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abideen, G; Adewumi, OO; Agbaje, EO; Akanmu, AS; Akinleye, MO; Akinyede, A; Busari, AA; Hassan, OO; Kadri, MR; Oreagba, IA; Usman, SO | 1 |
1 other study(ies) available for atazanavir sulfate and cgp-56697
| Article | Year |
|---|---|
Evaluation of the effects of atazanavir-ritonavir on the pharmacokinetics of lumefantrine in patients living with HIV in Lagos University Teaching Hospital, South-Western Nigeria.
Topics: Adult; Anti-Retroviral Agents; Antimalarials; Artemether, Lumefantrine Drug Combination; Atazanavir Sulfate; Case-Control Studies; Chromatography, High Pressure Liquid; Drug Combinations; Female; HIV Infections; Hospitals, Teaching; Humans; Malaria; Male; Middle Aged; Nigeria; Plasmodium falciparum; Racemases and Epimerases; Ritonavir | 2021 |